ECKERT & ZIEGLER SE (EUZ.DE) Stock Price, Forecast & Analysis

FRA:EUZ • DE0005659700

14.96 EUR
+0.36 (+2.47%)
Last: Feb 13, 2026, 07:00 PM

EUZ.DE Key Statistics, Chart & Performance

Key Statistics
Market Cap950.26M
Revenue(TTM)304.47M
Net Income(TTM)39.75M
Shares63.52M
Float42.78M
52 Week High34.88
52 Week Low14.25
Yearly Dividend0.02
Dividend Yield1.1%
EPS(TTM)0.65
PE23.02
Fwd PE17.9
Earnings (Next)05-12
IPO1999-05-25
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
EUZ.DE short term performance overview.The bars show the price performance of EUZ.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15

EUZ.DE long term performance overview.The bars show the price performance of EUZ.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40

The current stock price of EUZ.DE is 14.96 EUR. In the past month the price decreased by -8.67%. In the past year, price decreased by -49.92%.

ECKERT & ZIEGLER SE / EUZ Daily stock chart

EUZ.DE Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
EUZ.DE Full Technical Analysis Report

EUZ.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 7 / 10 to EUZ.DE. EUZ.DE scores excellent points on both the profitability and health parts. This is a solid base for a good stock.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
EUZ.DE Full Fundamental Analysis Report

EUZ.DE Financial Highlights

Over the last trailing twelve months EUZ.DE reported a non-GAAP Earnings per Share(EPS) of 0.65. The EPS increased by 43.67% compared to the year before.


Industry RankSector Rank
PM (TTM) 13.06%
ROA 8.79%
ROE 17.17%
Debt/Equity 0.16
Chartmill High Growth Momentum
EPS Q2Q%68.5%
Sales Q2Q%7.42%
EPS 1Y (TTM)43.67%
Revenue 1Y (TTM)9.64%
EUZ.DE financials

EUZ.DE Forecast & Estimates

8 analysts have analysed EUZ.DE and the average price target is 22.06 EUR. This implies a price increase of 47.44% is expected in the next year compared to the current price of 14.96.

For the next year, analysts expect an EPS growth of 52.31% and a revenue growth 8.58% for EUZ.DE


Analysts
Analysts80
Price Target22.06 (47.46%)
EPS Next Y52.31%
Revenue Next Year8.58%
EUZ.DE Analyst EstimatesEUZ.DE Analyst Ratings

EUZ.DE Ownership

Ownership
Inst Owners30.9%
Ins Owners0.23%
Short Float %N/A
Short RatioN/A
EUZ.DE Ownership

About EUZ.DE

Company Profile

EUZ logo image Eckert & Ziegler SE is a holding company, which engages in the processing of radio isotopes. The company is headquartered in Berlin, Berlin and currently employs 1,112 full-time employees. The firm operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.

Company Info

ECKERT & ZIEGLER SE

Robert-Roessle-Str.10

Berlin BERLIN DE

Employees: 1085

EUZ Company Website

EUZ Investor Relations

Phone: 49309410840

ECKERT & ZIEGLER SE / EUZ.DE FAQ

What does EUZ do?

Eckert & Ziegler SE is a holding company, which engages in the processing of radio isotopes. The company is headquartered in Berlin, Berlin and currently employs 1,112 full-time employees. The firm operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.


Can you provide the latest stock price for ECKERT & ZIEGLER SE?

The current stock price of EUZ.DE is 14.96 EUR. The price increased by 2.47% in the last trading session.


What is the dividend status of ECKERT & ZIEGLER SE?

ECKERT & ZIEGLER SE (EUZ.DE) has a dividend yield of 1.1%. The yearly dividend amount is currently 0.02.


How is the ChartMill rating for ECKERT & ZIEGLER SE?

EUZ.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 7 out of 10.


Which stock exchange lists EUZ stock?

EUZ.DE stock is listed on the Frankfurt Stock Exchange exchange.


Can you provide the sector and industry classification for ECKERT & ZIEGLER SE?

ECKERT & ZIEGLER SE (EUZ.DE) operates in the Health Care sector and the Health Care Equipment & Supplies industry.